Significance of comorbidity in cancers of the head and neck region

Journal of the Chinese Medical Association

Volumn 73, Issue 10, 2010, Pages 507-508

  Okuyemi, Oluwafunmilola T ^a   Dwivedi, Raghav C ^b   Kazi, Rehan ^b   Piccirillo, Jay F ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER MORTALITY; CANCER RISK; CANCER SURVIVAL; CARDIOVASCULAR DISEASE; COMORBIDITY; DIABETES MELLITUS; DISEASE SEVERITY; HEAD AND NECK CANCER; HUMAN; LUNG DISEASE; QUALITY OF LIFE; REVIEW;

COMORBIDITY; HEAD AND NECK NEOPLASMS; HEALTH CARE COSTS; HUMANS; QUALITY OF LIFE;

EID: 78049470790     PISSN: 17264901     EISSN: 17287731     Source Type: Journal    
DOI: 10.1016/S1726-4901(10)70109-X     Document Type: Review

References (11)

1. Piccirillo JF Importance of comorbidity in head and neck cancer. Laryngoscope 2000, 110:593-602.
2. Datema FR, Ferrier MB, van der Schroeff MP, Baatenburg de Jong RJ Impact of comorbidity on short-term mortality and overall survival of head and neck cancer patients. Head Neck 2010, 32:728-736.
3. Piccirillo JF, Lacy PD, Basu A, Spitznagel EL Development of a new head and neck cancer-specific comorbidity index. Arch Otolaryngol Head Neck Surg 2002, 128:1172-1179.
4. Piccirillo JF, Tierney RM, Costas I, Grove L, Spitznagel EL Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA 2004, 291:2441-2447.
5. Homma A, Sakashita T, Oridate N, Suzuki F, Suzuki S, Hatakeyama H, Mizumachi T, et al. Importance of comorbidity in hypopharyngeal cancer. Head Neck 2010, 32:148-153.
6. Terrell JE, Ronis DL, Fowler KE, Bradford CR, Chepeha DB, Prince ME, Teknos TN, et al. Clinical predictors of quality of life in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 2004, 130:401-408.
7. Ware JE, Sherbourne CD The MOS 36 Item Short-Form Health Survey (SF-36): I. Conceptual framework and item selection. Med Care 1992, 30:473-483.
8. Hollenbeak CS, Stack BC, Daley SM, Piccirillo JF Using comorbidity indexes to predict costs for head and neck cancer. Arch Otolaryngol Head Neck Surg 2007, 133:24-27.
9. de Groot V, Beckerman H, Lankhorst GJ, Bouter LM How to measure comorbidity: a critical review of available methods. J Clin Epidemiol 2003, 56:221-229.
10. Piccirillo JF, Costas I, Claybour P, Borah AJ, Grove L, Jeffe D The measurement of comorbidity by cancer registries. J Registry Manag 2003, 30:8-14.
11. Kazi R, Nutting CM, Rhys-Evans P, Harrington KJ Significance and prognostic impact of co-morbidity in head and neck cancer. J Cancer Res Ther 2009, 5:145-147.